1Alyea EP,Soiffer VT,Canning C,et al.Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse afer allogeneic bone marrow transplant[].Blood.1998 被引量：1
2Clare EJ,Alyea EP,Orsins E,et al.Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocte infusion[].The Journal of Clinical Investigation.1997 被引量：1
3Bosch G,Joosten A,Kessler J,et al.Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide[].Blood.1996 被引量：1
4Giralt S,Hester J,Huh Y,et al.CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation[].Blood.1995 被引量：1
5Keil F,Kalhs P,Haas OA,et al.Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaenia: successful treatment with cyclophosphamied and antithymocyte globulin followed by peripheral blood stem cell infusion[].British Journal of Haematology.1996 被引量：1
6Slavin S,Naparstek E,Nagler A,et al.Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes[].Experimental Hematology.1995 被引量：1
7Slavin S,Napayrstek E,Noglerv A,et al.Allogenetic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat Icukcmia relapse after allogeneic bone marrow transplantation[].Blood.1996 被引量：1
8Collins RH Jr,Shpilberg O,Drobyski WR,et al.Donor leukocyte infusions in 140 patients with rclapsed malignancy after allgeneic bone marrow transplantation[].Journal of Clinical Oncology.1997 被引量：1
9Atra A,Millar B,Shepherd V,et al.Donor lymphocyte infusion for childhood acute lymphoblastic leukaemia relapsing after bone marrow transplantaton[].British Journal of Haematology.1997 被引量：1
10Lokhorst HM,Schattenberg A,Cornelissen JJ,et al.Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bonc marrow transplantation[].Blood.1997 被引量：1
3Murphy W G.Prophylactic platelate transfusion in acute leukemia [J].Lancet,1992,339:120. 被引量：1
4Vander BJ,Vanden MA,Drabbels JJ,et al.Transfusion-associated graft vs.host disease after donor-soecific leukocyte transfusion before kidney transplantation[J].Clin Transplant,2003,17(5):477-483. 被引量：1
5Brubaker DB.Immunopathogenic mechanism of post transfusion graft-versus-host disease[J].Proc Soc Exp Biol Med,1993,202(2):122-125. 被引量：1
6Petz LD,Calboun L,Yam P,et al.Transfusion-associated graft-versus-host disease in immunocompetent patients:report of a fatal case associated with transfusion of blood from a second-degree relative and a survey of predisposing factors[J].Transfusion,1993,33(8):742-744. 被引量：1
8Ahya R,Douglas JG,Waston HG.Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting[J].Heart,1999,80(3):299-300. 被引量：1
9Aoun E,Shamseddine A,Chehal A,et al.Transfusion-assiciated GVHD:10 years' experience at the American University of Beirut-Medical Center[J].Transfusion,2003,43(12):1672-1676. 被引量：1
10Chang H,Voralia M,Bali M,et al.Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood[J].Br J Haematol,2000,111(1):146-156. 被引量：1
